VistaGen Therapeutics
VTGN
#10076
Rank
A$38.92 M
Marketcap
A$0.99
Share price
-6.21%
Change (1 day)
-79.30%
Change (1 year)

Market capitalization of VistaGen Therapeutics (VTGN)

Market cap: A$38.92 Million

As of January 2026 VistaGen Therapeutics has a market cap of A$38.92 Million. This makes VistaGen Therapeutics the world's 10076th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of VistaGen Therapeutics from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026A$38.92 M-9.38%
2025A$42.95 M-62.67%
2024A$0.11 B-43.57%
2023A$0.20 B551.22%
2022A$31.3 M-94.17%
2021A$0.53 B55.22%
2020A$0.34 B712.73%
2019A$42.57 M-35.61%
2018A$66.12 M112.22%
2017A$31.16 M-28.14%
2016A$43.36 M75.47%
2015A$24.71 M79.55%
2014A$13.76 M29.44%
2013A$10.63 M-21.78%
2012A$13.59 M-71.57%
2011A$47.81 M

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of VistaGen Therapeutics was reported to be:

A$38.92 Million
by Nasdaq info icon info icon
A$38.92 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
A$1.33 B 3,318.03%๐Ÿ‡บ๐Ÿ‡ธ USA